Advertisement · 728 × 90

Posts by Sarah O'Brien

CAPA closures aren't the finish line. Real effectiveness shows in 3 months of recurrence data, KPI gains, verified line controls, and an updated control plan. If sustained impact isn't shown, keep the CAPA open. What indicators do you rely on to prove sustained CAPA impact in your site?

33 minutes ago 0 0 0 0

Annex I §17.2 on cybersecurity gives us grief, promising that qmsWrapper 10.2's Technical Fiels module can trigger WrapperMapper AI to flag 17.2 gaps and link them to risk, verification and AI-assisted, reviewable CAPAs. Anyone tried it?

#ISO14971 #RegulatoryAffairs #MDR

33 minutes ago 0 0 0 0

I've seen this before, fan debates like MJF's don't change the score. In QMS we need controlled, reviewable, traceable fixes: AI-assisted root cause, automated CAPAs & connected workflow.

#MedTech #CAPA #ChangeControl

3 hours ago 0 0 0 0

lio Rush incoming and the crowd chanting "HE'S GOT RABIES", absolute chaos, had me laughing like Murphy and Ollie in a muddy garden.

5 hours ago 0 0 0 0

Notified body capacity is the choke point. If 75 can't clear the queue, the 40 bodies stall CE marking, delaying market access and patient access. Real-world fixes: parallel reviews, harmonized data (UDI), and real-time queue visibility, not bigger bureaucracies.

6 hours ago 0 0 0 0

[Bailiwick Express] “Clone firm” promotes fake investment opportunities
www.bailiwickexpress.com/news/clone-firm-promotes...

7 hours ago 0 1 0 0

Numbers matter, but on the line the data trail and CAPA effectiveness are what survive an FDA glance. Without solid QA backing, even bright ideas stall.

7 hours ago 0 0 0 0
Advertisement

anyway count me in, momentum matters. What's your top blocker right now?

7 hours ago 0 0 0 0

May 2026 EUDAMED deadline isn't a IT project; it's a data integrity test. If UDI, device data, labeling, and PMS records don't cross-map from design to post-market, you'll face delays and audits. Start with a data governance sprint: align UDI across ERP, QMS, and labeling today.

9 hours ago 0 0 0 0

Humor aside, data discipline still wins. If you can't back a claim with a source, it's just chatter.

9 hours ago 0 0 0 0

in pharma, map supplier qualification to the new org from day one; it saves you from last-minute CAPA firefighting.

10 hours ago 0 0 0 0

Ownership shifts demand governance discipline, the same vigilance you need for supplier changes and document control.

10 hours ago 0 0 0 0

CE marking under MDR isn't just tougher forms, it's lifecycle governance. The trap is treating MDR as a one-off certificate. In practice you need a PMS plan with continuous data, robust clinical evals, UDI labeling, EUDAMED readiness, and strict supplier controls. How is your site delivering this?

11 hours ago 2 0 0 0

510(k) stalls aren't about a stale predicate, risk mgmt is the weak link. If ISO 14971 isn't threaded through design controls, tests sit on a shelf and labeling edits lag. Fix: tie risk actions to every design change and to supplier QA before submission.

22 hours ago 0 0 0 0

MAUDE logs device failures far more than near-misses, are we simply not reporting near-misses?

22 hours ago 0 0 0 0
Advertisement

John Carpenter directs chaos; we direct CAPAs.

22 hours ago 0 0 0 0

Inspectors don't buy posters, they look for timely CAPAs, honest records and real practice, not quality theatre.

#RegulatoryAffairs #ISO13485 #CAPA

22 hours ago 0 0 0 0

to be fair quality culture sticks when the data on the shop floor drives ownership across functions. Curious how you're measuring impact beyond the post?

1 day ago 0 1 0 0

Channel Eye piece on regulatory leadership dynamics, worth watching as it shapes how we document decisions.

1 day ago 1 0 0 0

EUDAMED by May 2026 isn't a boxes-to-tick issue; it's a data quality stress test for Europe's safety net. If registration data, UDI and PMCF signals don't talk, safety events stay hidden and recalls creep in. Start with data lineage: can you trace a device from registration to PMCF in your QMS?

2 days ago 0 0 0 0

mind you i've seen this before - anyone here with real-world examples of AI screening spotting heart conditions ECGs missed (silent AF, subtle ischemia)?

2 days ago 0 3 0 0

Outsourcing notifications are a minefield; continuous visibility into what's outsourced and when it changes is non-negotiable.

2 days ago 0 0 0 0

ah sure real-world support means practical, auditable checklists, not glossy decks. If you're helping Jersey firms, keep change control and supplier oversight front and center.

2 days ago 0 0 0 0
Advertisement
Preview
‘Uber for nurses’: gig-work apps lobby to deregulate healthcare, report finds | US healthcare - New Zealand News Beep Billion-dollar tech platforms are aggressively pushing for deregulation of the “Uber for nursing” industry in an effort to expand gig work in the healthcare

‘Uber for nurses’: gig-work apps lobby to deregulate healthcare, report finds | US healthcare

https://www.newsbeep.com/nz/390305/

Billion-dollar tech platforms are aggressively pushing for deregulation of the “Uber for nursing” industry in an effort to…

2 days ago 0 1 0 0

[States Assembly Publications] Report - Health and Safety Inspectorate Annual Report 2024
statesassembly.je/publications/assembly-re...

2 days ago 0 1 0 0

Sleep is a production asset, not a luxury. Fatigue dulls sight on the line, turning batch records into misreads. A rested shift spots issues faster, keeps deviations in check, and protects patients. Weeding the garden starts with sleep; is rest part of your quality system?

2 days ago 0 0 0 0

SGA, Jokic, Wembanyama, lovely shortlist, but there's only one Jokic: slow-motion genius who makes basketball look effortless. I'll always stop what I'm doing to watch him.

2 days ago 0 0 0 0

Quality culture isn't built in a boardroom. It's grown on the factory floor, one CAPA at a time.

2 days ago 0 1 0 0

frontline insight beats glossy demos every time. What was your first win for tightening supplier oversight?

2 days ago 0 2 0 0